SUBSCRIBE
SUBSCRIBE

Panbela Therapeutics Inc.

IN THE PRESS
Business
Panbela to Host Third Quarter 2023 Earnings Conference Call on November 9, 2023
October 24, 2023
 · 
6 min read
Business
Panbela Announces Issuance of New Patent in China for Claims of a Novel Process for the Production of SBP-101Patent developed in collaboration with Syngene International Ltd.
September 26, 2023
 · 
8 min read
BioMidwest
Panbela to Present at the LD Micro Investor Conference
September 19, 2023
 · 
6 min read
BioMidwest
Panbela Announces Issuance of New Patent in Chile for Claims of a Novel Process for the Production of FlynpoviPatent developed in collaboration with Sanofi
September 5, 2023
 · 
7 min read
BioMidwest
Panbela to Present at H.C. Wainwright 25th Annual Global Investment Conference
August 28, 2023
 · 
6 min read
Business
Panbela Announces Issuance of New Patent in Europe for Claims of a Novel Process for the Production of SBP-101
August 14, 2023
 · 
8 min read
BioMidwest
Panbela Provides Business Update and Reports Q2 2023 Financial Results
August 10, 2023
 · 
13 min read
Business
Panbela to Host Second Quarter 2023 Earnings Conference Call on August 10, 2023
July 31, 2023
 · 
6 min read
BioMidwest
Panbela Opens Enrollment in UK and Germany for Aspire Trial in Pancreatic Cancer, All Countries/Regions in the Aspire Trial are Now Open and Actively EnrollingInterim Data Analysis anticipated in Early 2024
July 24, 2023
 · 
6 min read
BioMidwest
Panbela Therapeutics to Receive a Total Up to $9.5 Million for Divestiture of Assets within Eflornithine (DFMO) Pediatric Neuroblastoma Program to US WorldMeds
July 19, 2023
 · 
9 min read
Load More
JOBS